HYDERABAD, Feb 24 (Reuters) - U.S. drugmaker Amgen AMGN.O will invest about $200 million this year in its new technology centre in southern India, with further investments planned, Chief Executive Officer Robert A. Bradway said at the inauguration of the site.
(Reporting by Rishika Sadam, writing by Pushkala Aripaka)
((Pushkala.A@thomsonreuters.com; X and LinkedIn: @pullthekart;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.